These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39236366)
1. Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptors. Snelleksz M; Dean B Psychiatry Res; 2024 Nov; 341():116156. PubMed ID: 39236366 [TBL] [Abstract][Full Text] [Related]
2. Lower levels of soluble β-amyloid precursor protein, but not β-amyloid, in the frontal cortex in schizophrenia. Dean B; Duce J; Li QX; Masters CL; Scarr E Psychiatry Res; 2024 Jan; 331():115656. PubMed ID: 38071879 [TBL] [Abstract][Full Text] [Related]
3. Lower levels of kainate receptors, but not AMPA or NMDA receptors, in Brodmann's area (BA) 9, but not BA 10, from a subgroup of people with schizophrenia who have a marked deficit in cortical muscarinic M1 receptors. Snelleksz M; Scarr E; Dean B Schizophr Res; 2024 Dec; 274():129-136. PubMed ID: 39293250 [TBL] [Abstract][Full Text] [Related]
4. Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia. Hopper S; Pavey GM; Gogos A; Dean B Int J Neuropsychopharmacol; 2019 Oct; 22(10):640-650. PubMed ID: 31428788 [TBL] [Abstract][Full Text] [Related]
5. Lower levels of cortical [ Dean B; Haroutunian V; Scarr E Schizophr Res; 2023 May; 255():274-282. PubMed ID: 37079947 [TBL] [Abstract][Full Text] [Related]
6. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype. Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243 [TBL] [Abstract][Full Text] [Related]
7. Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Barakat A; Dean B; Scarr E; Evin G Schizophr Res; 2010 Dec; 124(1-3):200-7. PubMed ID: 20926259 [TBL] [Abstract][Full Text] [Related]
8. Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor. Scarr E; Udawela M; Thomas EA; Dean B Mol Psychiatry; 2018 Feb; 23(2):295-303. PubMed ID: 27801890 [TBL] [Abstract][Full Text] [Related]
9. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1. Dean B; Soulby A; Evin GM; Scarr E Schizophr Res; 2008 Dec; 106(2-3):229-36. PubMed ID: 18790604 [TBL] [Abstract][Full Text] [Related]
10. Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia. Scarr E; Cowie TF; Kanellakis S; Sundram S; Pantelis C; Dean B Mol Psychiatry; 2009 Nov; 14(11):1017-23. PubMed ID: 18317461 [TBL] [Abstract][Full Text] [Related]
11. Changes in levels of the zinc transporter SLC39A12 in Brodmann's area 44: Effects of sex, suicide, CNS pH and schizophrenia. Dean B; Hopper S; Scarr E J Psychiatr Res; 2024 Sep; 177():177-184. PubMed ID: 39024742 [TBL] [Abstract][Full Text] [Related]
12. Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorder. Snelleksz M; Dean B Psychiatry Res; 2021 Sep; 303():114096. PubMed ID: 34274903 [TBL] [Abstract][Full Text] [Related]
13. Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia. Gibbons AS; Scarr E; Boer S; Money T; Jeon WJ; Felder C; Dean B Int J Neuropsychopharmacol; 2013 Feb; 16(1):37-46. PubMed ID: 22338582 [TBL] [Abstract][Full Text] [Related]
14. No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophrenia. Scarr E; Keriakous D; Crossland N; Dean B Life Sci; 2006 Feb; 78(11):1231-7. PubMed ID: 16214178 [TBL] [Abstract][Full Text] [Related]
15. An investigation of the factors that regulate muscarinic receptor expression in schizophrenia. Seo MS; Scarr E; Dean B Schizophr Res; 2014 Sep; 158(1-3):247-54. PubMed ID: 25037527 [TBL] [Abstract][Full Text] [Related]
16. Higher levels of α7 nicotinic receptors, but not choline acetyltransferase, in the dorsolateral prefrontal cortex from a sub-group of patients with schizophrenia. Dean B; Pavey G; Scarr E Schizophr Res; 2020 Aug; 222():283-290. PubMed ID: 32507381 [TBL] [Abstract][Full Text] [Related]
17. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900 [TBL] [Abstract][Full Text] [Related]
18. A predicted cortical serotonergic/cholinergic/GABAergic interface as a site of pathology in schizophrenia. Dean B Clin Exp Pharmacol Physiol; 2001; 28(1-2):74-8. PubMed ID: 11153542 [TBL] [Abstract][Full Text] [Related]
19. Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia. Scarr E; Hopper S; Vos V; Seo MS; Everall IP; Aumann TD; Chana G; Dean B J Psychiatry Neurosci; 2018 Aug; 43(5):338-346. PubMed ID: 30125244 [TBL] [Abstract][Full Text] [Related]
20. Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia. Dean B; Thomas N; Scarr E; Udawela M Transl Psychiatry; 2016 Nov; 6(11):e949. PubMed ID: 27845781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]